Related Experiment Video

Updated: Apr 4, 2026

Assessing Specificity of Anticancer Drugs In Vitro
09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

9.9K

Personalized Devices Predict Cancer Drug Sensitivity In Vivo

Vijay Shankar Balakrishnan

    Journal of the National Cancer Institute
    |September 6, 2015
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
    09:19

    Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

    Published on: February 6, 2015

    9.3K
    An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
    09:41

    An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

    Published on: July 15, 2015

    9.2K

    Related Experiment Videos

    Last Updated: Apr 4, 2026

    Assessing Specificity of Anticancer Drugs In Vitro
    09:39

    Assessing Specificity of Anticancer Drugs In Vitro

    Published on: March 23, 2016

    9.9K
    Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
    09:19

    Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

    Published on: February 6, 2015

    9.3K
    An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
    09:41

    An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

    Published on: July 15, 2015

    9.2K

    Related Concept Videos

    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    6.3K
    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    6.3K

    Articles linked to this work by shared authors, journal, and citation graph.

    Timing of mental disorders in relation to cancer-specific mortality in cancer patients.

    Journal of the National Cancer Institute·2026

    Addressing the impact of tobacco and alcohol use on cancer-related health outcomes.

    Journal of the National Cancer Institute·2026

    Epigenetic aging of colorectal mucosa in cancer development.

    Journal of the National Cancer Institute·2026

    Randomized trial of adjuvant 5-FU-platinum vs paclitaxel-platinum for high-risk penile cancer.

    Journal of the National Cancer Institute·2026

    Concurrent chemotherapy and external radiation therapy (ConCERT): phase 3 noninferiority randomized clinical trial of cisplatin weekly vs every 3 weeks in locally advanced squamous cell carcinoma of the head and neck.

    Journal of the National Cancer Institute·2026

    Evaluating longitudinal toxicity and adverse event in cetuximab-treated metastatic colorectal cancer: a pooled analysis from 1,302 patients in ARCAD database.

    Journal of the National Cancer Institute·2026

    DLST Succinylation-Mediated Mitochondrial Metabolic Remodeling and Cuproptosis Resistance Promote Malignant Progression of Lung Adenocarcinoma.

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

    Deubiquitination of Vangl by USP6 and USP32 Regulates Planar Cell Polarity Signaling.

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

    Hsa_circ_0001839 is associated with poor prognosis and promotes tumor progression in gastric cancer.

    Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology·2026

    Liver transplant allocation by milan criteria may exclude eligible HCC patients without survival benefit - a post-hoc analysis of the SiLVER study.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026

    Human-relevant Ptpn6 mutation alters immune and hepatic functions during aging.

    Aging·2026

    ATP6L impairs vascular stability in colorectal cancer via PDGFB/PDGFRβ signaling.

    Bioscience trends·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us